Share
Market Research Report

NORTH AMERICA, EUROPE, AND AUSTRALIA PEANUT ALLERGY TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Drug TypeEpinephrine · Antihistamine · (Loratadine, Diphenhydramine, Others) · Palforzia · Pipeline Drugs (Viaskin Peanut, Ligelizumab, CA002, PRT120, Dupilumab)
  • By Route of AdministrationOral · Parenteral · Intranasal and Epicutaneous
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By GeographyNorth America · Europe · Australia
  • Published In16 Mar 2026
  • Report CodeCMI5041
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Distribution Channels 
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
    • Impact Analysis
    • Key developments
    • Pipeline Analysis
    • Collaborations and Agreements
    • Market Trends
    • Product Approval
    • Regulatory Scenario
    • PEST Analysis
    • PORTER’s Five Forces Analysis
    • Reimbursement Scenario
    • Prescriber Preference: Overview
    • Prescriber Overview
    • Treatment Algorithm
    • Epidemiology
  4. North America Europe and Australia Peanut Allergy Treatment Market, By Drug Type, 2026-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2020-2033
      • Segment Trends
    • Epinephrine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
    • Antihistamine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
        • Loratadine
        • Diphenhydramine
        • Others
      • Palforzia
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
      • Pipeline Drugs
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
          • Viaskin Peanut
          • Ligelizuma
          • CA002
          • PRT120
          • Dupilumab
  5. North America Europe and Australia Peanut Allergy Treatment Market, By Route of Administration, 2026-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2020-2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
    • Parenteral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
    • Intranasal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
    • Epicutaneous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
  6. North America Europe and Australia Peanut Allergy Treatment Market, By Distribution Channel, 2026-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2020-2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
  7. North America Europe and Australia Peanut Allergy Treatment Market, By Region, 2026-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2020–2031
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2033,(USD Mn)
        • U.S.
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Sub-region, 2020-2033,(USD Mn)
        • Canada
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2033,(USD Mn)
        • U.K.
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
        • Germany
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
        • France
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
        • Italy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
        • Spain
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
        • Russia
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
        • Rest of Europe
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
          • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
    • Australia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
  8. Competitive Landscape

    • Heat Map Analysis
    • Market Share Analysis
      • DBV Technologies
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Aimmune Therapeutics, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Prota Therapeutics Pty Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • COUR Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • BlueWillow Biologics
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • HAL Allergy B.V
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Allergy Therapeutics PLC
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Novartis AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Regeneron Pharmaceuticals, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Vedanta Biosciences, Inc
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Cambridge Allergy Ltd. (Camallergy)
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Angany Inc
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Moonlight Therapeutics Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Moonlight Therapeutics Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Allero Therapeutics B.V.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Sanofi
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Johnson & Johnson
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Viatris Inc. (Mylan N.V.)
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Sun Pharmaceutical Industries Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Bayer AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Aurobindo Pharma Limited.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Astellas Pharma Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Astellas Pharma Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Siolta Therapeutics
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • DESENTUM OY
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • ALK
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Immunomic Therapeutics, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Stallergenes Greer Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
  9. Section

    • Research Methodology
    • About Us and Services
    • Contact